Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros, Jean-Marc Sabatier
{"title":"SIBO:与多种严重和致残的COVID-19和长期COVID-19症状相关或由抗COVID-19疫苗诱导的“新”人类病理的线索","authors":"Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros, Jean-Marc Sabatier","doi":"10.2174/1871526523666230210162334","DOIUrl":null,"url":null,"abstract":"<jats:sec>\n<jats:title />\n<jats:p />\n</jats:sec>","PeriodicalId":13678,"journal":{"name":"Infectious disorders drug targets","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"SIBO: The Trail of a \\\"New\\\" Human Pathology Associated with Multiple Severe and Disabling COVID-19 and Long COVID Symptoms or Induced by the Anti-COVID-19 Vaccine.\",\"authors\":\"Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros, Jean-Marc Sabatier\",\"doi\":\"10.2174/1871526523666230210162334\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<jats:sec>\\n<jats:title />\\n<jats:p />\\n</jats:sec>\",\"PeriodicalId\":13678,\"journal\":{\"name\":\"Infectious disorders drug targets\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infectious disorders drug targets\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1871526523666230210162334\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious disorders drug targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871526523666230210162334","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
SIBO: The Trail of a "New" Human Pathology Associated with Multiple Severe and Disabling COVID-19 and Long COVID Symptoms or Induced by the Anti-COVID-19 Vaccine.
期刊介绍:
Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel human drug targets for anti-infective drug discovery continues to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.